1. Home
  2. |Insights
  3. |CPSC Streamlined Rule on Certification

CPSC Streamlined Rule on Certification

Client Alert | 1 min read | 11.12.08

On November 11, 2008, the Consumer Product Safety Commission ("CPSC") issued an immediately-effective final rule (16 CFR pt. 1110) streamlining certification requirements under the Consumer Product Safety Improvement Act of 2008 ("CPSIA") for foreign manufacturers and private labelers. [Click the link above to download a PDF of the final rule]

For imported products, the final rule designates the importer as "the sole entity that must issue the certificate required." The certificate must be available upon request when the product or shipment is available for inspection in the United States.

For domestically produced products, the final rule designates the domestic manufacturer as the sole entity required to issue the certificate. The certificate must be available upon request before the product or shipment is introduced into domestic commerce.

The final rule establishes that the required certificates may be available in electronic form for purposes of "accompanying" a shipment and being "furnished" to distributors and retailers. An acceptable electronic form is a unique identifier for the electronic version of the certificate accessible by a World Wide Web URL or other electronic means.

The CPSC cited the "extremely short deadline" for compliance with the certification requirement, the "vast expansion" of products covered by the requirement, and the confusion over the requirement as its justifications for streamlining the rule, "at least in its initial phase." The certification requirements established by the CPSIA go into effect for products manufactured on or after November 12, 2008.

Insights

Client Alert | 7 min read | 06.26.26

Federal Roundup: Updates for PBMs and Medicare Advantage Organizations

In June 2026, federal regulators and lawmakers continued their efforts to improve drug affordability through targeted reforms. These recent developments will primarily impact pharmaceutical manufacturers, managed care organizations, and pharmacy benefit managers (PBM) serving Medicare Part D program members. PBMs, Medicare Advantage organizations, and Part D sponsors should monitor these changes in the interest of maintaining compliance and providing input on regulatory proposals that may influence their business operations or compensation structures in the future....